• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL.

作者信息

Locatelli Franco, Valsecchi Maria Grazia, Möricke Anja, Zimmermann Martin, Gruhn Bernd, Biondi Andrea, Kulozik Andreas E, Silvestri Daniela, Bodmer Nicole, Putti Maria Caterina, Burdach Stefan, Micalizzi Concetta, Teigler-Schlegel Andrea, Ritter Jörg, Pession Andrea, Cario Gunnar, Bielack Stefan, Basso Giuseppe, Klingebiel Thomas, Vinti Luciana, Rizzari Carmelo, Attarbaschi Andishe, Santoro Nicola, Parasole Rosanna, Mann Georg, Karawajew Leonid, Haas Oskar A, Conter Valentino, Schrappe Martin

机构信息

Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Department of Pediatric Science, University of Pavia, Pavia, Italy.

出版信息

Blood. 2017 Nov 9;130(19):2146-2149. doi: 10.1182/blood-2017-05-782086. Epub 2017 Sep 22.

DOI:10.1182/blood-2017-05-782086
PMID:28939722
Abstract
摘要

相似文献

1
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL.在中度风险急性淋巴细胞白血病儿童的再诱导治疗期间，方案II与方案III均给予两次。
Blood. 2017 Nov 9;130(19):2146-2149. doi: 10.1182/blood-2017-05-782086. Epub 2017 Sep 22.
2
[Intensification of chemotherapy in maintenance therapy and in periodic reinduction of remission in high-risk childhood ALL].[高危儿童急性淋巴细胞白血病维持治疗及定期再诱导缓解中强化化疗]
An Esp Pediatr. 1988 Oct;29 Suppl 34:94-8.
3
[Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].儿童急性淋巴细胞白血病骨髓复发再诱导化疗的研究
Rinsho Ketsueki. 1989 Nov;30(11):1923-30.
4
[Report on induction efficacy of protocol ALL-2005 and middle term follow-up of 158 cases of childhood acute lymphoblastic leukemia].[儿童急性淋巴细胞白血病158例ALL-2005方案诱导缓解疗效及中期随访报告]
Zhonghua Xue Ye Xue Za Zhi. 2009 May;30(5):289-93.
5
[Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].[单克隆抗体在儿童急性淋巴细胞白血病中的应用。II. 特定免疫亚组的临床表现和预后]
Pediatr Pol. 1988 Nov;63(11):698-702.
6
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.风险导向治疗后急性淋巴细胞白血病患儿的低复发率
J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. doi: 10.1097/00043426-200112000-00008.
7
[Treatment of children with recurrent acute lymphoblastic leukemia].
Pediatriia. 1989(4):62-5.
8
[Comparison of the present and previously used protocol of risk stratification in children with acute lymphoblastic leukemia].[急性淋巴细胞白血病患儿当前与既往使用的风险分层方案比较]
Med Wieku Rozwoj. 2007 Apr-Jun;11(2 Pt 1):153-8.
9
Evaluation of different induction regimens in children with acute lymphocytic leukemia.
Indian J Pediatr. 1988 Sep-Oct;55(5):789-95. doi: 10.1007/BF02734304.
10
Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.中低收入国家儿童急性淋巴细胞白血病的治疗结果：墨西哥东北部 10 年经验。
Arch Med Res. 2016 Nov;47(8):668-676. doi: 10.1016/j.arcmed.2017.01.004.

引用本文的文献

1
Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective.儿童急性淋巴细胞白血病的治疗：历史视角
Cancers (Basel). 2024 Feb 8;16(4):723. doi: 10.3390/cancers16040723.
2
Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria.前瞻性地使用分子微小残留病进行儿童和青少年急性淋巴细胞白血病的风险分层：奥地利 AIEOP-BFM ALL 2000 试验的长期结果。
Wien Klin Wochenschr. 2024 Jul;136(13-14):405-418. doi: 10.1007/s00508-023-02249-6. Epub 2023 Aug 3.
3
Hypersensitivity Reactions to Native L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction.
在ALL-BFM 2000试验中接受治疗的急性淋巴细胞白血病儿童对天然L-天冬酰胺酶的超敏反应：诱导治疗方案和糖皮质激素类型的影响
Hemasphere. 2023 Jun 1;7(6):e888. doi: 10.1097/HS9.0000000000000888. eCollection 2023 Jun.
4
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331.标准风险 B 细胞急性淋巴细胞白血病患儿的结局：儿童肿瘤学组 AALL0331 试验结果。
J Clin Oncol. 2020 Feb 20;38(6):602-612. doi: 10.1200/JCO.19.01086. Epub 2019 Dec 11.